• Explore /
  • Poster
  • / Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer.

Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer.

Abstract Poster

Authors

null

Robert R. McWilliams

Mayo Clinic, Rochester, MN;

Robert R. McWilliams , Pashtoon Murtaza Kasi , Nathan R. Foster , Mojun Zhu , Ryan Michael Carr , Wen Wee Ma , Mindy L. Hartgers , Kayla M. Jones , Jacqueline M. Bartusiewicz , Haidong Dong , Svetomir Markovic , Steven R Alberts , Daniel H. Ahn , Hani M. Babiker , Tanios S. Bekaii-Saab , Fergus Couch

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04493060

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS780)

DOI

10.1200/JCO.2023.41.4_suppl.TPS780

Abstract #

TPS780

Poster Bd #

Q16

Abstract Disclosures

Similar Posters

First Author: Severine Guiu Lahaye

First Author: Qiuxiang Ou

First Author: Anup Kasi

Poster

2023 ASCO Annual Meeting

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

First Author: Muhammad Danyal Ahsan